NOTABLE ARTICLES OF 2016 - A collection of important studies from the past year as selected by NEJM editors
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
NOTABLE ARTICLES OF 2016 A collection of important studies from the past year as selected by NEJM editors
December 2016 Dear Reader, In 2016, the Journal published trials that sought to answer complicated questions. One such study looked at whether men with early prostate cancer should undergo prostatectomy, radiation, or “watchful waiting” to achieve the best outcome at 10 years. This study found that men with low-risk or intermediate-risk prostate cancer had low prostate-cancer–specific mortality after 10 years, irrespective of the treatment assigned. Importantly, these data helped with the conundrum of treating prostate cancer. Since this is a disease of older men, the study balanced the competing issues of aggressive treatment of a redolent disease with the reality that other factors may claim the life of the patient before he suc- cumbs to prostate cancer. It provided solid landmarks for men wrestling with what to do when they were diagnosed with low-intermediate risk prostate cancer. Another study examined whether inducing labor at 39 weeks in pregnant women 35 years of age or older, compared to expectant management, reduced stillbirth. While the study was underpowered to assess differences in perinatal outcomes, it found no effect between the two groups on the rate of caesarean section. This trial makes an important contribution to our current medical knowledge, and helps build the foundation for larger, forthcoming studies. And even without larger studies, the data presented helped pregnant women and their physicians visualize the risks and benefits of inducing labor. As the medical information published in NEJM is regularly used in daily practice, we ensure each paper published meets exacting standards for editorial quality, clinical relevance, and impact on patient out- comes. Among all papers published in 2016, this “most notable” collection was selected by the editors as being the most meaningful in improving medical practice and patient care. We hope that you will take valuable insights from these articles as you continue along your path of lifelong learning. Jeffrey M. Drazen, M.D. Editor-In-Chief, The New England Journal of Medicine Distinguished Parker B. Francis Professor of Medicine Harvard Medical School 800.843.6356 | f: 781.891.1995 | nejmgroup@mms.org 860 winter street, waltham, ma 02451-1413 nejmgroup.org
contents original article Incidence of Dementia over Three Decades in the Framingham Heart Study............................................. 1 perspective Is Dementia in Decline? Historical Trends and Future Trajectories........................................ 2 original article Effects of Testosterone Treatment in Older Men........................................................................................... 5 editorial Establishing a Framework — Does Testosterone Supplementation Help Older Men? ��������� 6 original article National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical Training........................................ 8 editorial Surgical Resident Duty-Hour Rules — Weighing the New Evidence....................................... 9 perspective Leaping without Looking — Duty Hours, Autonomy,and the Risks of Research and Practice.............................................................................................................................. 11 original article Randomized Trial of Labor Induction in Women 35 Years of Age or Older............................................... 14 editorial Induction of Labor and Cesarean Delivery.............................................................................. 15 original articles Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis......................................... 17 Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis.................................. 18 editorial Endarterectomy, Stenting, or Neither for Asymptomatic Carotid-Artery Stenosis................ 19 original articles Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease......................... 21 Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease............................... 22 Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease............................ 23 editorial More HOPE for Prevention with Statins.................................................................................. 24 original article Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older................................... 27 editorial Preventing Shingles and Its Complications in Older Persons................................................ 28 (continued on next page) The New England Journal of Medicine is a publication of NEJM Group, a division of the Massachusetts Medical Society. ©2016 Massachusetts Medical Society, All rights reserved.
contents (continued from previous page) original articles 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer................. 30 original article Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.................. 31 editorial Treatment or Monitoring for Early Prostate Cancer................................................................ 32 original article Guillain–Barré Syndrome Associated with Zika Virus Infection in Colombia............................................. 34 editorial Zika Getting on Your Nerves? The Association with the Guillain–Barré Syndrome.............. 35 original article A Randomized Trial of Long-term Oxygen for COPD with Moderate Desaturation .................................. 37 editorial Clinical Usefulness of Long-Term Oxygen Therapy in Adults................................................. 38 perspective Zika Virus in the Americas — Yet Another Arbovirus Threat ..................................................................... 40 perspective Reducing the Risks of Relief — The CDC Opioid-Prescribing Guideline ................................................... 44 perspective Rethinking the Primary Care Workforce — An Expanded Role for Nurses................................................. 48
1 Notable Articles of 2016 nejm.org The n e w e ng l a n d j o u r na l of m e dic i n e Original Article Incidence of Dementia over Three Decades in the Framingham Heart Study Claudia L. Satizabal, Ph.D., Alexa S. Beiser, Ph.D., Vincent Chouraki, M.D., Ph.D., Geneviève Chêne, M.D., Ph.D., Carole Dufouil, Ph.D., and Sudha Seshadri, M.D. A BS T R AC T BACKGROUND The prevalence of dementia is expected to soar as the average life expectancy in- From the Boston University Schools of creases, but recent estimates suggest that the age-specific incidence of dementia Medicine (C.L.S., A.S.B., V.C., S.S.) and Public Health (A.S.B.), Boston, and the is declining in high-income countries. Temporal trends are best derived through Framingham Heart Study, Framingham continuous monitoring of a population over a long period with the use of consis- (C.L.S., A.S.B., V.C., S.S.) — all in Mas- tent diagnostic criteria. We describe temporal trends in the incidence of dementia sachusetts; and Inserm Unité 1219 and CIC 1401-EC (Clinical Epidemiology) and over three decades among participants in the Framingham Heart Study. University of Bordeaux, ISPED (Bordeaux School of Public Health) — both in Bor- METHODS deaux, France (G.C., C.D.). Address re- Participants in the Framingham Heart Study have been under surveillance for in- print requests to Dr. Seshadri at the Bos- ton University School of Medicine, cident dementia since 1975. In this analysis, which included 5205 persons 60 years Department of Neurology, 72 E. Concord of age or older, we used Cox proportional-hazards models adjusted for age and sex St., B602, Boston, MA 02118, or at to determine the 5-year incidence of dementia during each of four epochs. We also suseshad@bu.edu. explored the interactions between epoch and age, sex, apolipoprotein E ε4 status, N Engl J Med 2016;374:523-32. and educational level, and we examined the effects of these interactions, as well DOI: 10.1056/NEJMoa1504327 Copyright © 2016 Massachusetts Medical Society. as the effects of vascular risk factors and cardiovascular disease, on temporal trends. Read Full Article at NEJM.org RESULTS The 5-year age- and sex-adjusted cumulative hazard rates for dementia were 3.6 per 100 persons during the first epoch (late 1970s and early 1980s), 2.8 per 100 persons during the second epoch (late 1980s and early 1990s), 2.2 per 100 persons during the third epoch (late 1990s and early 2000s), and 2.0 per 100 persons during the fourth epoch (late 2000s and early 2010s). Relative to the incidence during the first epoch, the incidence declined by 22%, 38%, and 44% during the second, third, and fourth epochs, respectively. This risk reduction was observed only among persons who had at least a high school diploma (hazard ratio, 0.77; 95% confi- dence interval, 0.67 to 0.88). The prevalence of most vascular risk factors (except obesity and diabetes) and the risk of dementia associated with stroke, atrial fibril- lation, or heart failure have decreased over time, but none of these trends com- pletely explain the decrease in the incidence of dementia. CONCLUSIONS Among participants in the Framingham Heart Study, the incidence of dementia has declined over the course of three decades. The factors contributing to this decline have not been completely identified. (Funded by the National Institutes of Health.) n engl j med 374;6 nejm.org February 11, 2016 523 Back to Table of Contents
2 Notable Articles of 2016 nejm.org PE R S PE C T IV E Is Dementia in Decline? Is Dementia in Decline? His tory of Medicine Is Dementia in Decline? Historical Trends and Future Trajectories David S. Jones, M.D., Ph.D., and Jeremy A. Greene, M.D., Ph.D. Related article, p. 523 I n 2005, researchers from the Duke Center for Demographic Studies reported a “surprising in the dementia epidemic? The potential decline of dementia, seen in light of the rise and fall be extremely difficult to produce timely and convincing data about the trajectories of chronic dis- trend”: data from the National of other major diseases, raises an eases.4 When physicians began to Long-Term Care Surveys showed even more tantalizing prospect: debate CAD trends in 1974, they that the prevalence of severe cog- Can we control our burden of had to rely on government data nitive impairment in the Medi- disease? that were 5 years out of date. It care population had decreased This is not the first time that took 4 years of concerted effort significantly between 1982 and the medical profession and the to reach consensus about an in- 1999.1 At a time when baby- public health community have flection that had occurred more boomer demographics led to pre- struggled to interpret reports of an than a decade earlier. Even though dictions of a looming dementia unexpected reversal of a chronic- better and timelier data are now crisis, this finding offered hope. disease epidemic.4 In 1964, Cali- available, dementia researchers Since that time, other reports fornia health officials reported must still be resourceful in seek- have similarly shown that the in- that rates of coronary artery dis- ing convincing data. As Satizabal cidence or prevalence of demen- ease (CAD) had begun to de- et al. indicate, each existing re- tia is decreasing in various popu- crease. This finding, which defied port has limitations. Their new lations. Researchers have offered the widespread belief that the data, which overcome many of many possible explanations, in- CAD epidemic would only worsen these limitations, demonstrate the cluding increased wealth, better as life expectancy grew, garnered value of investments in long-term, education, control of vascular risk scant attention. Even a decade longitudinal epidemiologic re- factors, and use of statins, anti- later, most health officials as- search such as the Framingham hypertensive agents, and nonste- sumed that CAD was still on the Heart Study. But the data still re- roidal antiinflammatory drugs.1,2 rise. It was only in 1974 that re- flect only one population sample. However, even as researchers de- searchers began taking the pros- Whether they are accepted as scribe their “cautious optimism” pect of decline seriously. By 1978, conclusive evidence of a broad- about specific populations, they they had accepted that CAD’s na- based reduction in dementia in- still project a quadrupling of tional decline had begun in the cidence will become clear only global prevalence over the com- mid-1960s. Similar decreases were over time. ing decades.3 soon reported in many other high- Second, since trajectories of In this issue of the Journal, income countries, from Australia chronic-disease incidence reflect Satizabal and colleagues report to Finland. This recognition trig- complex interactions of many more “robust evidence” of demen- gered debate over the contribu- causal factors, it will almost al- tia’s decline (pages 523–32). Using tion of medical and public health ways be uncertain whether de- surveillance data collected from interventions, in hopes that knowl- creases will continue or reverse. the Framingham Heart Study edge of the causes of decline Even as consensus about interna- from 1975 to the present, they would guide policies and resource tional CAD reduction consolidat- found a 20% decrease in demen- allocation and ensure continua- ed between the 1970s and the tia incidence each decade, even tion of these health benefits. 1990s, worrisome evidence about as average body-mass index, dia- The history of the debate on countervailing trends also ap- betes prevalence, and population CAD decline carries important peared.4 Enthusiasm for anti-CAD age have increased. Can we now lessons for emerging reports of public health campaigns has been conclude that the tide has turned dementia’s decline. First, it can fragile, even in countries like n engl j med 374;6 nejm.org February 11, 2016 507 Back to Table of Contents
3 Notable Articles of 2016 nejm.org PE R S PE C T IV E Is Dementia in Decline? Finland that demonstrated their 1980s, even after CAD’s decline trol of infectious disease led to promise so well. The widespread had been accepted and despite dramatic gains in life expectancy, increases in obesity and diabetes knowledge that dementia shares physicians in the early 20th cen- could fuel CAD resurgences. many risk factors with CAD, phy- tury came to see CAD and cancer Many researchers have warned sicians began to warn about an as the inevitable scourges of long that CAD’s decline could stall or exploding dementia epidemic.5 lives. Over recent decades, that even reverse — something that The decrease in prevalence that pessimism has largely given way has happened among young surprised Manton and colleagues as well: CAD and many forms of adults and other subpopulations in 2005 could have been predict- cancer are increasingly prevent- in Europe, Australia, and the ed decades earlier. But dementia able and curable. The burden of United States. Other countries, will remain a problem despite disease of the 20th century, like such as China, continue to see these decreases. The prevalence that of the 19th, was not an in- increases in CAD with no evi- of dementia can increase, even if evitable fact of life, but a product dence of plateau or reversal. the incidence falls, if global pop- of lives lived amid specific — and malleable — conditions. What should we expect as can- History offers reasons for hope. cer and heart disease come under Evidence of dementia’s decline shows control? Many people think that we can live even longer lives — once again that our burden of disease but lives compromised by demen- tia, vision loss, and hearing loss. is malleable. Whether that fate is inevitable or whether these, too, are malleable All these countervailing trends ulations live longer. The absolute scourges remains to be seen. could affect dementia as well. number of people with dementia Such questions are better left to Rocca and colleagues have warned can increase, even if both inci- futurists and geriatricians than that increases in obesity, diabetes, dence and prevalence fall, if the to historians. Yet Satizabal et al. and hypertension could under- size of the elderly population believe there’s cause for “cautious mine the gains achieved through grows. That explains why, 10 years hope.” Primary and secondary pre- improved education, wealth, and into the era of reports of decreas- vention might diminish the mag- control of vascular risk factors. ing dementia in selected popula- nitude of the long-feared dementia Even if a dementia decline has tions, Satizabal and colleagues epidemic. Something else might begun, it might not last: the out- still write that the “prevalence of save our vision and hearing. come depends on the balance of dementia is expected to soar as Faced with choices between diverging trends.2,3 our societies age.” Even research- equally defensible epidemiologic Third, these ambiguities open ers rigorously examining the evi- projections, physicians and re- up a battleground for conflicting dence of decreases continue to searchers must think carefully interpretations by interested par- worry about what the future will about what stories they empha- ties. Policymakers can use the bring. size to patients and policymak- same data to tell vastly different History offers reasons for ers. The implications, especially stories about public health. Fore- hope. Evidence of dementia’s de- for investment in long-term care casts of CAD’s future continue to cline shows once again that our facilities, are enormous. Our ex- swing between narratives of tri- burden of disease is malleable. planations of decline are equally umph and catastrophe.4 The good This lesson has been hard won. important, since they guide in- news is that more and more Mid-19th-century physicians saw vestments in behavior change, countries are reporting evidence cholera and tuberculosis as in- medications, and other treat- of decline. The bad news is the evitable scourges of urban envi- ments. evidence of the fragility of these ronments. But those epidemics With this latest contribution, gains. yielded to sanitary reform, im- optimism about dementia is more Narratives of dementia remain proved standards of living, and justified than ever before. Even if similarly malleable. In the early eventually medical care. As con- death and taxes remain inevita- 508 n engl j med 374;6 nejm.org February 11, 2016 Back to Table of Contents
4 Notable Articles of 2016 nejm.org PER S PE C T IV E Is Dementia in Decline? ble, cancer, CAD, and dementia Disclosure forms provided by the authors sights into the dementia epidemic. N Engl J are available with the full text of this article Med 2013;369:2275-7. may not. But cautious optimism at NEJM.org. 3. Rocca WA, Petersen RC, Knopman DS, should not become complacency. et al. Trends in the incidence and prevalence From the Department of Global Health and If we can elucidate the changes Social Medicine, Harvard Medical School, of Alzheimer’s disease, dementia, and cog- nitive impairment in the United States. Al- that have contributed to these Boston (D.S.J); the Department of the His- zheimers Dement 2011;7:80-93. improvements, perhaps we can ex- tory of Science, Harvard University, Cam- 4. Jones DS, Greene JA. The decline and bridge, MA (D.S.J.); and the Division of tend them. Today, the dramatic General Internal Medicine and the Depart- rise of coronary heart disease: understand- ing public health catastrophism. Am J Pub- reductions in CAD-related mor- ment of the History of Medicine, Johns lic Health 2013;103:1207-18. tality are under threat. The incipi- Hopkins University School of Medicine, 5. Beck JC, Benson DF, Scheibel AB, Spar Baltimore (J.A.G.). ent improvements in dementia JE, Rubenstein LZ. Dementia in the elderly: 1. Manton KC, Gu XL, Ukraintseva SV. De- the silent epidemic. Ann Intern Med 1982; are presumably even more fragile. 97:231-41. clining prevalence of dementia in the U.S. el- The burden of disease, ever mal- derly population. Adv Gerontol 2005;16:30-7. DOI: 10.1056/NEJMp1514434 leable, can easily relapse. 2. Larson EB, Yaffe K, Langa KM. New in- Copyright © 2016 Massachusetts Medical Society. Is Dementia in Decline? n engl j med 374;6 nejm.org February 11, 2016 509 Back to Table of Contents
5 Notable Articles of 2016 nejm.org new england The journal of medicine established in 1812 February 18, 2016 vol. 374 no. 7 Effects of Testosterone Treatment in Older Men P.J. Snyder, S. Bhasin, G.R. Cunningham, A.M. Matsumoto, A.J. Stephens-Shields, J.A. Cauley, T.M. Gill, E. Barrett-Connor, R.S. Swerdloff, C. Wang, K.E. Ensrud, C.E. Lewis, J.T. Farrar, D. Cella, R.C. Rosen, M. Pahor, J.P. Crandall, M.E. Molitch, D. Cifelli, D. Dougar, L. Fluharty, S.M. Resnick, T.W. Storer, S. Anton, S. Basaria, S.J. Diem, X. Hou, E.R. Mohler III, J.K. Parsons, N.K. Wenger, B. Zeldow, J.R. Landis, and S.S. Ellenberg, for the Testosterone Trials Investigators* a bs t r ac t BACKGROUND Serum testosterone concentrations decrease as men age, but benefits of raising testos- The authors’ full names, academic de- terone levels in older men have not been established. grees, and affiliations are listed in the Ap- pendix. Address reprint requests to Dr. METHODS Snyder at pjs@mail.med.upenn.edu. We assigned 790 men 65 years of age or older with a serum testosterone concentration * A complete list of investigators in the of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive Testosterone Trials is provided in the either testosterone gel or placebo gel for 1 year. Each man participated in one or more Supplementary Appendix, available at NEJM.org. of three trials — the Sexual Function Trial, the Physical Function Trial, and the Vital- ity Trial. The primary outcome of each of the individual trials was also evaluated in all Drs. Bhasin, Cunningham, Matsumoto, Stephens-Shields, and Ellenberg contrib- participants. uted equally to this article. RESULTS N Engl J Med 2016;374:611-24. Testosterone treatment increased serum testosterone levels to the mid-normal range for DOI: 10.1056/NEJMoa1506119 men 19 to 40 years of age. The increase in testosterone levels was associated with sig- Copyright © 2016 Massachusetts Medical Society. nificantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P
6 Notable Articles of 2016 nejm.org The n e w e ng l a n d j o u r na l of m e dic i n e Edi t or i a l Establishing a Framework — Does Testosterone Supplementation Help Older Men? Eric S. Orwoll, M.D. Aging is variably but inevitably accompanied by anemia, bone density, and cardiovascular status). declines in health; concomitantly, in men, circu- The trials are knitted together by common lating sex-steroid levels fall with age.1 To what methods and some shared measures, thus maxi- extent these two processes are causally linked mizing the power of the overall investigation. and whether testosterone therapy can prevent or This inaugural report describes the findings of ameliorate important age-related problems have the three main studies (with primary outcomes been major issues in men’s health. In 2003, a com- related to sexual function, physical function, mittee assembled by the Institute of Medicine and vitality). (IOM) found a paucity of randomized, placebo- The results show that testosterone therapy did controlled clinical trials involving older men and yield certain benefits, but at this point their noted a lack of definite evidence that testoster- clinical importance is uncertain. Therapy was one therapy conferred benefits.2 The committee not a panacea, and the findings alone might be recommended that clinical trials be initiated, insufficient to support a decision to initiate tes- first to evaluate the efficacy of testosterone tosterone therapy in symptomatic older men. The supplementation in older men and then to assess study confirmed that testosterone supplementa- long-term benefits and risks through large-scale tion can yield improvements in sexual function, trials. but the benefits were modest, tended to wane in Little has changed to alter the conclusions of the latter months of the treatment period, and, that report; if anything, the issue of testosterone as the authors note, were not as robust as those supplementation has become more controversial.3 of phosphodiesterase type 5 inhibitors.6 There However, in this issue of the Journal, Snyder et al.4 were only small gains in physical performance describe the long-awaited initial results of the and in indexes of mood and depression; overall National Institutes of Health–sponsored Testos- vitality was no better with testosterone therapy terone Trials, which were designed to address than with placebo. For each of the outcomes, the key issues identified by the IOM. Their re- some older men may have a more vigorous re- port is important, not only because it deals with sponse to testosterone therapy and thus could be an essential public health issue but also because more attractive candidates for supplementation; the investigators have succeeded in conducting however, it was not possible to confidently iden- the kind of generally well-conceived studies that tify them by the testosterone levels achieved are sorely needed in the field. The findings be- with therapy. As expected, estradiol levels also gin to provide a basis for more rational clinical increased; those levels have been linked to key decisions about testosterone use as well as for health variables in men (e.g., sexual function).7 additional research. It’s not yet clear whether responses (or the lack The overall design of the Testosterone Trials is thereof) in the Testosterone Trials may be due to complex.5 It includes seven independent, double- changes in estradiol levels. blind, placebo-controlled trials intended to ad- There is considerable controversy about pos- dress specific outcomes that are postulated to be sible adverse effects of testosterone therapy in related to testosterone deficiency (sexual function, older men, and these studies do not resolve this vitality, physical function, cognitive function, controversy. Although there were minor effects 682 n engl j med 374;7 nejm.org February 18, 2016 Back to Table of Contents
7 Notable Articles of 2016 nejm.org Editorial on hemoglobin and prostate-specific antigen late controversy and to engender additional re- levels, and, reassuringly, no apparent major search questions — as did the Women’s Health toxic effects, larger and more extended trials Initiative with respect to estrogen-replacement would be needed to determine whether therapy therapy. Nevertheless, it is a landmark study in has negative effects on outcomes such as pros- the field of men’s health and no doubt a bell- tate or cardiovascular health. wether for additional important contributions Importantly, the study participants were re- from the Testosterone Trials. cruited on the basis of stringent criteria (age ≥65 Disclosure forms provided by the author are available with the years, total testosterone levels below the normal full text of this article at NEJM.org. range in men 19 to 40 years of age [
8 Notable Articles of 2016 nejm.org new england The journal of medicine established in 1812 February 25, 2016 vol. 374 no. 8 National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical Training Karl Y. Bilimoria, M.D., M.S.C.I., Jeanette W. Chung, Ph.D., Larry V. Hedges, Ph.D., Allison R. Dahlke, M.P.H., Remi Love, B.S., Mark E. Cohen, Ph.D., David B. Hoyt, M.D., Anthony D. Yang, M.D., John L. Tarpley, M.D., John D. Mellinger, M.D., David M. Mahvi, M.D., Rachel R. Kelz, M.D., M.S.C.E., Clifford Y. Ko, M.D., M.S.H.S., David D. Odell, M.D., M.M.Sc., Jonah J. Stulberg, M.D., Ph.D., M.P.H., and Frank R. Lewis, M.D. a bs t r ac t BACKGROUND Concerns persist regarding the effect of current surgical resident duty-hour policies on From the Surgical Outcomes and Quality patient outcomes, resident education, and resident well-being. Improvement Center (SOQIC), Depart- ment of Surgery and Center for Health- METHODS care Studies, Feinberg School of Medicine and Northwestern Medicine, Northwest- We conducted a national, cluster-randomized, pragmatic, noninferiority trial involving ern University (K.Y.B., J.W.C., A.R.D., R.L., 117 general surgery residency programs in the United States (2014–2015 academic year). A.D.Y., D.M.M., D.D.O., J.J.S.), and the Programs were randomly assigned to current Accreditation Council for Graduate Medical American College of Surgeons (K.Y.B., M.E.C., D.B.H., C.Y.K.), Chicago, the De- Education (ACGME) duty-hour policies (standard-policy group) or more flexible policies partment of Statistics, Northwestern Uni- that waived rules on maximum shift lengths and time off between shifts (flexible-policy versity, Evanston (L.V.H.), and the De- group). Outcomes included the 30-day rate of postoperative death or serious complica- partment of Surgery, Southern Illinois University, Springfield (J.D.M.) — all in tions (primary outcome), other postoperative complications, and resident perceptions Illinois; the Department of Surgery, and satisfaction regarding their well-being, education, and patient care. Vanderbilt University, Nashville (J.L.T.); the Department of Surgery and the Cen- RESULTS ter for Surgery and Health Economics, In an analysis of data from 138,691 patients, flexible, less-restrictive duty-hour policies Perelman School of Medicine, University were not associated with an increased rate of death or serious complications (9.1% in the of Pennsylvania (R.R.K.), and the Ameri- can Board of Surgery (F.R.L.) — both in flexible-policy group and 9.0% in the standard-policy group, P = 0.92; unadjusted odds Philadelphia; and the Department of Sur- ratio for the flexible-policy group, 0.96; 92% confidence interval, 0.87 to 1.06; P = 0.44; gery, University of California, Los Ange- noninferiority criteria satisfied) or of any secondary postoperative outcomes studied. les, School of Medicine, Los Angeles (C.Y.K.). Address reprint requests to Dr. Among 4330 residents, those in programs assigned to flexible policies did not report Bilimoria at the Surgical Outcomes and significantly greater dissatisfaction with overall education quality (11.0% in the flexible- Quality Improvement Center (SOQIC), policy group and 10.7% in the standard-policy group, P = 0.86) or well-being (14.9% and Department of Surgery, Feinberg School of Medicine and Northwestern Medicine, 12.0%, respectively; P = 0.10). Residents under flexible policies were less likely than those Northwestern University, 633 N. St. Clair under standard policies to perceive negative effects of duty-hour policies on multiple St., 20th Fl., Chicago, IL 60611, or at aspects of patient safety, continuity of care, professionalism, and resident education but k-bilimoria@northwestern.edu. were more likely to perceive negative effects on personal activities. There were no sig- This article was published on February 2, nificant differences between study groups in resident-reported perception of the effect of 2016, at NEJM.org. fatigue on personal or patient safety. Residents in the flexible-policy group were less N Engl J Med 2016;374:713-27. likely than those in the standard-policy group to report leaving during an operation (7.0% DOI: 10.1056/NEJMoa1515724 Copyright © 2016 Massachusetts Medical Society. vs. 13.2%, P
9 Notable Articles of 2016 nejm.org The n e w e ng l a n d j o u r na l of m e dic i n e Edi t or i a l Surgical Resident Duty-Hour Rules — Weighing the New Evidence John D. Birkmeyer, M.D. Surgical training has always been hard on resi- general-surgery training programs were required dents. During my own residency more than 20 to adhere to the ACGME rules about maximum years ago, 100-hour workweeks and in-house call shift length and minimum time off between 24- every other night were routine. A resident’s life hour shifts. Another 59 programs were granted outside the hospital was simply not a priority. “flexibility” and did not have to adhere to those Residency may be even harder on patients. A large rules. Both groups adhered to ACGME require- body of research has linked sleep deprivation in ments for total workweek hours. Residents who resident physicians to poor performance in neu- were not required to adhere to the duty-hour rules robehavioral testing and, more alarmingly, to were less likely to report dissatisfaction with higher rates of attention failure in patient care.1,2 continuity of care and hand-offs. After 1 year, Reacting to concerns about both resident well- however, the two groups of teaching hospitals being and patient safety, the Accreditation Coun- had virtually indistinguishable rates of death, cil for Graduate Medical Education (ACGME) overall complications, and specific types of com- implemented duty-hour reforms in 2003 that plications, on the basis of data on risk-adjusted constrained resident workweeks to 80 hours, clinical outcomes from the American College of among other changes. A 2011 update added new Surgeons National Surgical Quality Improvement limits to the length of individual shifts (24 hours Program. plus 4 hours for transition) and guaranteed a It is not surprising that outcomes did not minimum amount of time off between 24-hour vary according to whether programs adhered to shifts (14 hours). Although they are not nearly as ACGME requirements on maximum shift length stringent as standards set in other occupations and time off between shifts. The patients most in which performance has implications for pub- likely to be affected by resident handoffs — lic safety (e.g., airline pilots), the ACGME rules those with acute or deteriorating clinical condi- were nonetheless criticized by many in the medi- tions — represent only a small percentage of cal community. Surgeons in particular were surgical patients at teaching hospitals. More concerned that the new duty-hour rules would important, teaching hospitals have become far paradoxically increase medical errors as a result less reliant on surgical residents than they used of increased handoffs — residents signing out to be. In earlier eras, surgical residents had con- their sickest patients to providers who are not siderable autonomy. During my own residency, familiar with their cases. In other words, the surgical residents often operated independently, safety benefits of reducing resident fatigue would particularly at night and on weekends. Today, be offset by harms associated with disrupting they operate almost exclusively in the presence continuity of care. of an attending surgeon. Intensive care units, Extending the results of a previous national which house the sickest surgical patients, are study based on Medicare claims data,3 a very increasingly “closed” and staffed by board-certi- ambitious, scientifically robust study by Bilimoria fied intensivists. Postoperative care is delivered et al. now published in the Journal should help by multidisciplinary teams staffed with associate allay these concerns.4 By random assignment, 59 providers as well as residents. n engl j med 374;8 nejm.org February 25, 2016 783 Back to Table of Contents
10 Notable Articles of 2016 nejm.org Editorial The Flexibility in Duty Hour Requirements for cal leaders should focus on developing safe, re- Surgical Trainees (FIRST) Trial also assessed the silient health systems that do not depend on effects of ACGME duty-hour restrictions on resi- overworked resident physicians. They should also dent perceptions of educational quality and well- recognize the changing expectations of post- being, with the use of survey data collected millennial learners. To many current residents annually by the American Board of Surgery. and medical students, 80-hour (or even 72-hour) Residents in the two groups of teaching hospi- workweeks and 24-hour shifts probably seem tals had similarly high rates of satisfaction with long enough. Although few surgical residents the quality of their training. Although residents in would ever acknowledge this publicly, I’m sure programs not required to adhere to the ACGME that many love to hear, “We can take care of this duty-hour rules were more likely to be dissatis- case without you. Go home, see your family, and fied with time for rest, there were no significant come in fresh tomorrow.” differences in overall resident well-being and Disclosure forms provided by the author are available with the morale between the two groups. full text of this article at NEJM.org. What do the results of the FIRST Trial mean From the Dartmouth–Hitchcock Medical Center and the Dart- for ACGME policy on resident duty hours? The mouth Institute for Health Policy and Clinical Practice — both authors conclude, as will many surgeons, that in Lebanon, NH. surgical training programs should be afforded more flexibility in applying work-hour rules. This article was published on February 2, 2016, at NEJM.org. This interpretation implicitly places the burden 1. Veasey S, Rosen R, Barzansky B, Rosen I, Owens J. Sleep loss of proof on the ACGME. Thus, because the and fatigue in residency training: a reappraisal. JAMA 2002;288: FIRST Trial found no evidence that removing 1116-24. restrictions on resident shift length and time 2. Lockley SW, Cronin JW, Evans EE, et al. Effect of reducing interns’ weekly work hours on sleep and attentional failures. off between shifts was harmful to patients, N Engl J Med 2004;351:1829-37. programs should have more autonomy to train 3. Volpp KG, Rosen AK, Rosenbaum PR, et al. Mortality among residents as they choose. hospitalized Medicare beneficiaries in the first 2 years following ACGME resident duty hour reform. JAMA 2007;298:975-83. I reach a different conclusion. The FIRST Trial 4. Bilimoria KY, Chung JW, Hedges LV, et al. National cluster- effectively debunks concerns that patients will randomized trial of duty-hour flexibility in surgical training. suffer as a result of increased handoffs and N Engl J Med 2016;374:713-27. breaks in the continuity of care. Rather than DOI: 10.1056/NEJMe1516572 backtrack on the ACGME duty-hour rules, surgi- Copyright © 2016 Massachusetts Medical Society. 784 n engl j med 374;8 nejm.org February 25, 2016 Back to Table of Contents
11 Notable Articles of 2016 nejm.org The NEW ENGLA ND JOURNAL of MEDICINE Perspective February 25, 2016 Leaping without Looking — Duty Hours, Autonomy, and the Risks of Research and Practice Lisa Rosenbaum, M.D. Related article, p. 713 I Leaping without Looking n 2014, Facebook users were furious to discover randomization at the residency- that they’d unwittingly been experimented on.1 program level, and neither required consent of residents or patients. Researchers had randomly assigned users to news That consent waiver has drawn feeds with reduced “positive” content or reduced criticism from Public Citizen and the American Medical Student “negative” content and found that leveled at investigators who are Association, which in open letters happy posts beget happy posts comparing the 2011 duty-hour to the Office for Human Research and that grim ones beget grim restrictions imposed by the Ac- Protections (OHRP) accuse the in- ones.2 Although that may now creditation Council for Graduate vestigators of “egregious ethical seem obvious, previous evidence Medical Education (ACGME) with and regulatory violations.”3,4 had suggested that because we more flexible shift lengths for The allegations, focused pri- tend to compare ourselves to oth- residents. The Flexibility in Duty marily on “serious health risks” ers, exposure to positive content Hour Requirements for Surgical to residents from long shifts, are compromises users’ well-being. Trainees (FIRST) trial, whose re- dizzyingly tautological. The critics There was thus no reason to be- sults are now reported by Bilimo- claim it’s unethical not to obtain lieve that the status quo — news ria et al. in the Journal, compared residents’ consent; but because feeds curated by an algorithm 59 surgical training programs pressure on residents to conform tailored to users’ viewing habits — randomly assigned to an ACGME- makes seeking their consent akin was any “safer” than the experi- compliant schedule with 58 grant- to coercion, that’s unethical too. mental interventions. And given ed flexibility in designing shift Thus, there’s no ethical way to Facebook’s reach, there were com- lengths (still within an 80-hour study the duty-hour rules in a pelling reasons to find out. Never- workweek). The ongoing Individ- randomized fashion. But that’s theless, the results triggered out- ualized Comparative Effectiveness fine, because we already know rage that 700,000 users had been of Models Optimizing Safety and they’re beneficial; we know that exposed to potential emotional Resident Education (iCOMPARE) because the ACGME made the damage without their consent. trial involves internal medicine rules in the first place. And if the Similar accusations have been programs. Both used cluster trials found otherwise, their re- n engl j med 374;8 nejm.org February 25, 2016 701 Back to Table of Contents
12 Notable Articles of 2016 nejm.org Leaping without Looking PER S PE C T IV E sults challenging the status quo tional toll of “work compression” gaged in hand-offs, leave halfway would be suspect because the in- and the reality that many trainees through an operation because vestigators, who have publicly ac- don’t actually sleep more, they your shift’s up, or perceive resent- knowledged the need for data to also speak to a fundamental ment in your supervisors who inform policy, are consequently challenge in improving care: the think you have it easier than they too biased to generate those data. factors affecting physicians’ per- did. Given such trade-offs and To unpack these allegations, formance are so numerous and uncertainties, it’s not just ethical it’s important to understand that interdependent that no single vari- but laudable to comparatively even if the trials are considered able, such as sleep, can be under- evaluate duty-hours policies. The question then becomes: Can the No drug would be approved solely research be accomplished if con- sent is required? on the basis of laboratory evidence. Yet we The Facebook experiment’s re- sults would have been invalid had require neither consideration of complexity consent been sought, since we nor rigorous studies before implementing couldn’t determine how much users adjusted their emotional policies with broad implications. Why? content because they knew it was being monitored. Similarly, requir- human-subjects research, there stood or targeted in isolation. Be- ing residents’ consent in duty- are circumstances under which cause of the unknown real-life hour trials would render the re- federal rules deem it ethical to consequences of such myriad in- sults uninterpretable, given the waive consent. The key one here teractions, no drug would be ap- selection bias that would be intro- is that the incremental risk posed proved solely on the basis of lab- duced if those preferring longer by the research should be, at oratory evidence. Yet we require hours were more likely to par- most, minimal. For trials like neither consideration of complex- ticipate. these that evaluate a standard ity nor rigorous studies before The challenges with regard to practice, the question becomes: implementing policies with simi- patients are more pragmatic. Con- Is there equipoise between the larly broad implications. Why? sider, for instance, caring for a status quo and investigational Bioethicist and legal scholar man with a myocardial infarc- groups in terms of possible risks? Michelle Meyer has described our tion. After obtaining his consent Though the letters to OHRP “tendency to view a field experi- for percutaneous coronary inter- claim otherwise, the answer is un- ment designed to study the ef- vention, you’d have to add, “I also equivocally yes. The complaints fects of an existing or proposed need your consent to be cared for ignore a considerable body of re- practice as more morally suspi- by residents who are working search suggesting, as Bilimoria cious than an immediate, univer- longer hours.” If he said no, et al. point out, that duty-hour re- sal implementation of an untest- would you have to transfer him, forms have not improved patient ed practice.” She argues that as heart muscle continued to die, safety; some trials have even people in power often rely on in- to a nonteaching hospital? Surely raised concerns that they’ve actu- tuition in creating and imple- here the risk posed by seeking ally worsened quality of care and menting wide-reaching policies. consent is greater than that from patient outcomes. Indeed, neither residents nor pa- the research itself. As for risks to residents, the tients consented to the ACGME Moreover, as we examine the letters cite data suggesting that rules, yet no one finds this omis- implications for efforts to develop fatigue causes harms such as in- sion ethically suspect. Moreover, “learning health systems,” a corol- creased motor vehicle accidents, intuition seems particularly sa- lary of this hypothetical situation needlesticks, and burnout. Yet lient to debates over duty hours, is worth considering. Imagine tell- there’s little evidence to suggest since everyone knows how it ing a patient, “I need your per- that shorter hours have reduced feels to be tired. Unfortunately, mission to care for you at a hos- occupational hazards or burnout few people know how it feels to pital where we’re using a new rates. Though I suspect that these see a patient through illness, electronic health record, are bas- findings partly reflect the emo- spend a fifth of your time en- ing your doctor’s reimbursement 702 n engl j med 374;8 nejm.org February 25, 2016 Back to Table of Contents
13 Notable Articles of 2016 nejm.org PER S PE C T IV E Leaping without Looking on whether you stay healthy, and must understand the values of the slept but should remain foremost are under pressure to discharge people we’re professing to pro- in our discussions. An essential you quickly and make sure you tect. In one relevant study, Hal- contribution of the duty-hour don’t come back. We don’t really pern and colleagues asked patients trials is that, in assessing flexi- know how all this will affect your undergoing dialysis to imagine bility itself, they remind us that health, but we believe it’s for the two hypothetical scenarios.5 In autonomy is an ethical concept better. Can you sign here?” the “research scenario,” patients that matters to both doctors and The point is that our approach in a trial are randomly assigned patients — in research and in to human-subjects research per- to a prespecified dialysis dura- practice. petuates a misleading distinction tion of 4.5 hours or a duration at Disclosure forms provided by the author between risks posed by research the physician’s discretion (both are available with the full text of this article at NEJM.org. and those posed by practice, de- approaches are within the stan- manding greater scrutiny for in- dard of care). In the “clinical Dr. Rosenbaum is a national correspondent vestigative efforts while assum- care scenario,” patients receive di- for the Journal. ing that untested practice is safe. alysis for a duration determined This article was published on February 2, In describing this phenomenon, by a protocol (also common prac- 2016, and updated on February 4, 2016, at Meyer cites the moratorium that tice). Participants were more will- NEJM.org. the OHRP imposed on a study ing in the research than the 1. Meyer MN. Two cheers for corporate ex- assessing a checklist designed practice setting to give up their perimentation: the A/B illusion and the vir- to reduce catheter-related blood- own decision-making autonomy, tues of data-driven innovation. Colo Tech L J 2015;13(2):273. stream infections because re- including written informed con- 2. Kramer ADI, Guillory JE, Hancock JT. searchers hadn’t obtained physi- sent. They recognized the value Experimental evidence of massive-scale emo- cians’ or patients’ consent. The of research and didn’t perceive tional contagion through social networks. Proc Natl Acad Sci U S A 2014;111:8788-90. OHRP explained that its regula- the hypothetical study as posing 3. Carome MA, Wolfe SM, Almashat S, tions don’t apply when institu- higher risk than ordinary care. Hall DV. Letter to Jerry Menikoff, director, tions are merely “implementing” But they expressed deep reserva- and Kristina Borror, director, Division of Compliance Oversight, Office for Human practices aiming to improve care, tions about compromising physi- Research Protections, Department of Health but if they’re “planning research cians’ autonomy to individualize and Human Services, regarding iCOMPARE activities examining the effective- treatment absent compelling rea- trial. November 19, 2015 (http://www.citizen .org/documents/2283.pdf). ness of interventions to improve sons for doing so. 4. Carome MA, Wolfe SM, Almashat S, the quality of care, then the reg- This last finding highlights Hall DV. Letter to Jerry Menikoff, director, ulatory protections are important the ultimate irony of both duty- and Kristina Borror, director, Division of Compliance Oversight, Office for Human to protect the rights and welfare hour restrictions and objections Research Protections, Department of Health of human research subjects.” This to studying them: we’ve created and Human Services, regarding FIRST trial. double standard leaves us, para- an educational system that com- November 19, 2015 (http://www.citizen.org/ documents/2284.pdf). doxically, with unregulated prac- promises trainees’ freedom to 5. Kraybill A, Dember LM, Joffe S, et al. tices that may be ineffective and judge for themselves when their Patient and physician views about proto- unsafe because we can’t surmount patients need them. The value colized dialysis treatment in randomized tri- als and clinical care. AJOB Empirical Bioeth- the regulatory hurdles to conduct- that physicians and patients place ics 2015 October 23 (Epub ahead of print). ing research to improve them. on such autonomy is not measur- DOI: 10.1056/NEJMp1600233 Pharmaceutical Policy Reform To address this problem, we able in mortality rates or hours Copyright © 2016 Massachusetts Medical Society. Leaping without Looking n engl j med 374;8 nejm.org February 25, 2016 703 Back to Table of Contents
14 Notable Articles of 2016 nejm.org new england The journal of medicine established in 1812 March 3, 2016 vol. 374 no. 9 Randomized Trial of Labor Induction in Women 35 Years of Age or Older Kate F. Walker, M.R.C.O.G., George J. Bugg, M.D., Marion Macpherson, M.D., Carol McCormick, M.Sc., Nicky Grace, M.A., Chris Wildsmith, B.A., Lucy Bradshaw, M.Sc., Gordon C.S. Smith, D.Sc., and James G. Thornton, M.D., for the 35/39 Trial Group* a bs t r ac t BACKGROUND The risk of antepartum stillbirth at term is higher among women 35 years of age or From the Division of Child Health, Ob- older than among younger women. Labor induction may reduce the risk of stillbirth, stetrics and Gynaecology, School of Clin- ical Sciences (K.F.W., M.M., C.M., J.G.T.), but it also may increase the risk of cesarean delivery, which already is common in and Nottingham Clinical Trials Unit (L.B.), this older age group. and the University of Nottingham, the Division of Obstetrics and Gynaecology, METHODS Nottingham University Hospitals NHS Trust (G.J.B., N.G.), Nottingham, Still- We conducted a randomized, controlled trial involving primigravid women who were birth and Neonatal Death Charity, Lon- 35 years of age or older. Women were randomly assigned to labor induction between don (C.W.), and the Department of Ob- 39 weeks 0 days and 39 weeks 6 days of gestation or to expectant management (i.e., stetrics and Gynaecology and National Institute for Health Research Biomedical waiting until the spontaneous onset of labor or until the development of a medical Research Centre, Cambridge University, problem that mandated induction). The primary outcome was cesarean delivery. The Cambridge (G.C.S.S.) — all in the United trial was not designed or powered to assess the effects of labor induction on stillbirth. Kingdom. Address reprint requests to Dr. Thornton at the Division of Child Health, RESULTS Obstetrics and Gynaecology, School of Medicine, University of Nottingham, A total of 619 women underwent randomization. In an intention-to-treat analysis, Hucknall Rd., Nottingham NG5 1PB, there were no significant between-group differences in the percentage of women who United Kingdom, or at jim.thornton@ underwent a cesarean section (98 of 304 women in the induction group [32%] and nottingham.ac.uk. 103 of 314 women in the expectant-management group [33%]; relative risk, 0.99; 95% * A complete list of investigators in the confidence interval [CI], 0.87 to 1.14) or in the percentage of women who had a 35/39 Trial Group is provided in the Supplementary Appendix, available with vaginal delivery with the use of forceps or vacuum (115 of 304 women [38%] and 104 the full text of this article at NEJM.org. of 314 women [33%], respectively; relative risk, 1.30; 95% CI, 0.96 to 1.77). There were N Engl J Med 2016;374:813-22. no maternal or infant deaths and no significant between-group differences in the DOI: 10.1056/NEJMoa1509117 women’s experience of childbirth or in the frequency of adverse maternal or neonatal Copyright © 2016 Massachusetts Medical Society. outcomes. CONCLUSIONS Read Full Article at NEJM.org Among women of advanced maternal age, induction of labor at 39 weeks of gestation, as compared with expectant management, had no significant effect on the rate of cesarean section and no adverse short-term effects on maternal or neonatal out- comes. (Funded by the Research for Patient Benefit Programme of the National Insti- tute for Health Research; Current Controlled Trials number, ISRCTN11517275.) n engl j med 374;9 nejm.org March 3, 2016 813 Back to Table of Contents
15 Notable Articles of 2016 nejm.org The n e w e ng l a n d j o u r na l of m e dic i n e Edi t or i a l Induction of Labor and Cesarean Delivery William A. Grobman, M.D. At the heart of obstetrical care is a seemingly or perinatal outcomes have been too small to simple calculus: when are the benefits of deliv- guide clinical practice.7 ery greater than the benefits of continued preg- In this issue of the Journal, Walker et al.8 have nancy? However, making this determination is attempted to rectify this gap in evidence. They anything but straightforward, given the poten- report the results of a trial in which more than tially conflicting needs of the mother and the 600 women who were at least 35 years of age needs of her offspring, which must both be were randomly assigned to labor induction be- taken into account to maximize maternal and tween 39 weeks 0 days and 39 weeks 6 days of perinatal health. gestation or to expectant management. This In the absence of maternal or fetal complica- study was powered to detect at least a 36% rela- tions, current consensus favors the consideration tive difference between the two groups in the of delivery between 41 weeks 0 days and 42 weeks frequency of cesarean delivery. A total of 32% 0 days of gestation. In addition, for these women, of the women assigned to the induction group, delivery is recommended after 42 weeks 0 days as compared with 33% of the women assigned to and no later than 42 weeks 6 days of gestation, the expectant-management group, underwent a given the increase in perinatal morbidity and cesarean delivery (relative risk, 0.99; 95% confi- mortality at these gestational ages.1 Thus, induc- dence interval, 0.87 to 1.14). There were no sig- tion before 41 weeks 0 days of gestation in the nificant differences between the groups in other absence of complications is considered not to be adverse maternal or perinatal outcomes, but such medically indicated. outcomes were uncommon. One consideration that traditionally has tipped On the basis of the results of this trial, it the balance toward continuing pregnancy is the would be premature to alter recommendations concern that labor induction may increase the regarding the timing of delivery in uncomplicated risk of cesarean delivery, particularly among pregnancies. Although the study did not show nulliparous women. This belief is based on the evidence of harm from induction at 39 weeks findings of multiple observational studies in of gestation, it also did not show evidence of which outcomes in women who underwent in- benefit, and one could argue that medical inter- duction were compared with those of women ventions in general, and intervention in the who had spontaneous labor.2 However, sponta- natural progress of gestation specifically, should neous labor is not a clinical “strategy,” and thus be performed only when benefit has been shown. it is not the appropriate comparison. Because this trial was not designed or ade- Observational studies in which outcomes in quately powered to assess differences in perinatal women who underwent induction were compared outcomes, whether labor induction at 39 weeks of with those in women who received expectant gestation affects these outcomes remains un- management generally have not shown an in- known. We do not know whether the findings of creased risk of cesarean delivery among women this trial are generalizable to women younger who underwent induction.3-6 However, trials that than 35 years of age or whether the results have explored whether, in the absence of compli- would differ according to whether or not women cations, labor induction before 41 weeks 0 days require cervical ripening. Finally, women in this of gestation is associated with adverse maternal trial received care in the United Kingdom, which 880 n engl j med 374;9 nejm.org March 3, 2016 Back to Table of Contents
You can also read